FDA Expands Use of Convalescent Plasma to Treat COVID-19

The FDA is expanding the use of convalescent plasma to treat COVID-19 patients. It’s an experimental treatment that hasn’t been clinically proven, but doctors — including here in North Texas — have been using it on their critically ill patients. NBC 5 health reporter Bianca Castro asks to Dr. John Burk, the first physician in Fort Worth to use the treatment on a patient to weigh in.